
- Volume 0 0
can you READ these Rxs?
Pharmacist Charles DeBoyce and staff, of PriceChopper Pharmacy #134 in Oneonta, New York,were not sure what medication was being prescribedwhen the patient dropped off this scriptat the counter. After a call to the prescribingphysician's office for clarification, DeBoycelearned that the drug being ordered is notcommercially available in the strength prescribed.Can you figure out what this medicineis?
Registered Pharmacist Cecil Shern, of Cecil'sPharmacy in Lehi, Utah, was stumped when thisprescription was brought into the pharmacy. Thepatient was unable to provide any clues for thismystery script. Shern called the prescribingphysician's office for verification. The physician'snurse was able to unravel the mystery.Can you decode this prescription?
ANSWERS
Rx 1: Dexedrine 5 mg, #120, 2 tablets bid.
Rx 2: Decadron 3 mg, #90, take 1 tablet po tid, 3 refills.
Read the answers
function showAnswer() {document.getElementById("answer").style.display = 'block';document.getElementById("link").style.display = 'none';}
Have eye-straining, baffling prescriptions? Send them to Pharmacy Times.Along with a clean photocopy of the prescription itself, your submission must include: (1) the name of your institution and its location; (2)your name and title (PharmD, RPh, Pharm Tech); (3) the correct name of the drug(s), strength, and dosing requirements; and (4) your telephonenumber. Please mail your submissions to: Can You Read These Rxs?, Pharmacy Times, 103 College Road East, Princeton, NJ 08540.
Articles in this issue
over 17 years ago
No Nuts! Dealing with Nut Allergiesover 17 years ago
Case Studiesover 17 years ago
HYPERTENSION WATCHover 17 years ago
ASTHMA WATCHover 17 years ago
DIABETES WATCHover 17 years ago
compounding HOTLINEover 17 years ago
pharmacy TECHNOLOGY newsover 17 years ago
Clopidogrel: Some Drugs May Reduce Its Effectivenessover 17 years ago
RX PRODUCT Newsover 17 years ago
otc PRODUCT newsNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.